Chemed Corp. (NYSE:CHE) EVP Spencer S. Lee sold 2,000 shares of Chemed Corp. stock in a transaction that occurred on Wednesday, April 2nd. Chemed Corporation (NYSE:CHE) shares after opening at $90.47 moved to $91.40 on last trade day and at the end of the day closed at $90.87. Company price to sales ratio in past twelve months was calculated as 1.14 and price to cash ratio as 19.09. Chemed Corporation (NYSE:CHE) showed a positive weekly performance of 5.44%.
Cara Therapeutics, Inc. (NASDAQ:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pain by selectively targeting kappa opioid receptors, announced that Dr. Derek Chalmers, President and CEO, will present a company overview at the 13th Annual Needham Healthcare Conference on Wednesday, April 9, 2014 at 9:20 a.m. ET in New York City. Cara Therapeutics Inc. (NASDAQ:CARA) shares advanced 3.74% in last trading session and ended the day on $19.97. CARA return on equity ratio is recorded as 18.80% and its return on assets is -55.20%.
Brookdale Senior Living, Inc. (NYSE:BKD) announced that Tricia Conahan has joined the company in the newly created position of Executive Vice President and Chief Marketing Officer.
Brookdale Senior Living, Inc. (NYSE:BKD) shares moved up 1.18% in last trading session and was closed at $34.24, while trading in range of $33.88 – $34.80. Brookdale Senior Living, Inc. (NYSE:BKD) year to date (YTD) performance is 25.97%.
National HealthCare Corporation (NYSEMKT:NHC), one of the nation’s oldest publicly traded long-term health care providers and a leader of post-acute care services, announced on 5 march the expansion of its Missouri operations. National HealthCare Corporation (NYSEMKT:NHC) weekly performance is 3.78%. On last trading day company shares ended up $57.35. National HealthCare Corporation (NYSEMKT:NHC) distance from 50-day simple moving average (SMA50) is 10.18%.
Leave a Reply